PCOC
BIO icon

Power Corp of Canada’s Bio-Rad Laboratories Class A BIO Stock Holding History

Power Corp of Canada’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-568
Closed -$204K – 169
2023
Q3 		$204K Hold
568
– – 0.01% 153
2023
Q2 		$215K Buy
+568
New +$231K 0.02% 154

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Power Corp of Canada's BIO Position: Q4 2023 in Review

Power Corp of Canada sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 568 shares — an estimated $204K sold.

Power Corp of Canada first reported a position in BIO in Q2 2023 and held it in 2 quarters. The position peaked at $215K in Q2 2023. 483 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

  • Power Corp of Canada reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
  • Power Corp of Canada sold 568 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $204K.
  • Power Corp of Canada first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and held it in 2 quarters.
  • Power Corp of Canada's Bio-Rad Laboratories Class A position peaked at $215K in Q2 2023.
  • 483 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Power Corp of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.